Literature DB >> 2020666

Thickening of muscularis mucosae in Crohn's disease.

E Y Lee1, W F Stenson, K DeSchryver-Kecskemeti.   

Abstract

Crohn's disease (CD) of the bowel showed a statistically significant thickening of the muscularis mucosae when compared with disease controls. In areas of gross stricture in CD, the muscularis mucosae comprised almost 10% of total wall thickness. Similar findings were also present in a previously characterized experimental model of CD (trinitrobenzene sulfonic acid-induced colitis in rats), particularly in what appeared to be grossly strictured areas. Taken together, these findings suggest that increased mass of muscularis mucosae smooth muscle may be responsible in part for the commonly observed stricture formation in CD. As extreme muscularis mucosae hyperplasia appears to be peculiar to CD, it may serve as an additional marker differentiating CD from other diseases.

Entities:  

Mesh:

Year:  1991        PMID: 2020666

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy.

Authors:  Chao Li; Kent Vu; Krystina Hazelgrove; John F Kuemmerle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-01       Impact factor: 4.052

2.  Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease.

Authors:  Robert S Flynn; Karnam S Murthy; John R Grider; John M Kellum; John F Kuemmerle
Journal:  Gastroenterology       Date:  2009-09-12       Impact factor: 22.682

3.  Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis.

Authors:  Xuan-Zheng Shi; John H Winston; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-14       Impact factor: 4.052

4.  Tenascin-C is a driver of inflammation in the DSS model of colitis.

Authors:  James Ozanne; Brandon Shek; Louise A Stephen; Amanda Novak; Elspeth Milne; Gerry Mclachlan; Kim S Midwood; Colin Farquharson
Journal:  Matrix Biol Plus       Date:  2022-05-23

5.  Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation.

Authors:  Martin Floer; David G Binion; Victoria M Nelson; Sharon Manley; Michael Wellner; Saba Sadeghi; Behnaz Behmaram; Chloe Sewell; Mary F Otterson; Torsten Kucharzik; Parvaneh Rafiee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-17       Impact factor: 4.052

Review 6.  Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.

Authors:  Chadalavada Vijay Krishna; Jagmohan Singh; Chellappagounder Thangavel; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-28       Impact factor: 4.052

7.  Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's Disease.

Authors:  Mathilde Wagner; Huaibin Mabel Ko; Manjil Chatterji; Cecilia Besa; Joana Torres; Xiaofei Zhang; Hinaben Panchal; Stefanie Hectors; Judy Cho; Jean-Frederic Colombel; Noam Harpaz; Bachir Taouli
Journal:  J Crohns Colitis       Date:  2018-05-25       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.